Please login to the form below

Not currently logged in


This page shows the latest Dayvigo news and features for those working in and with pharma, biotech and healthcare.

Merck gets Alzheimer’s label claim for insomnia drug Belsomra

Merck gets Alzheimer’s label claim for insomnia drug Belsomra

Since then, it’s been joined on the market by Eisai’s recently-approved Dayvigo (lemborexant), which is also being tested in Alzheimer’s-relate sleep disturbances and reported positive results

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts


Add my company

Fox&cat is a new kind of fully-integrated communications agency – one that delivers genuinely inspirational campaigns and programmes with equal...

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story
Working together to achieve better patient pathways
Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.
How design can lead improvement within Pharma...